1. Origins and development of chemotherapy research at the National Cancer Institute;Zubrod;Cancer Treat Rep,1984
2. Phase I and pharmacokinetic study of ABI-007, a cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel;Ibrahim;Clin Cancer Res,2002
3. A phase I trial of ABI-007, nanoparticle paclitaxel, administered to patients with advanced non-hematologic malignancies;Nyman;Proc Am Assoc Cancer Res,2004
4. Phase I and pharmacokinetics (PK) of DJ-927, an oral taxane, in patients (Pts) with advanced cancers;Syed;Proc Am Soc Clin Oncol,2004
5. Phase 1 study of CT-2103 in patients with non-small cell lung cancer;Shipley;Proc Am Soc Clin Oncol,2003